342 related articles for article (PubMed ID: 22172912)
21. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
22. Prevention of cutaneous damages induced by radiotherapy in breast cancer: an institutional experience.
Ravo V; Calvanese MG; Di Franco R; Crisci V; Murino P; Manzo R; Morra A; Cammarota F; Muto P
Tumori; 2011; 97(6):732-6. PubMed ID: 22322839
[TBL] [Abstract][Full Text] [Related]
23. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
24. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
[TBL] [Abstract][Full Text] [Related]
25. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
26. A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.
Long X; Guo J; Yin Y; Cheng M; Zhang X; Zhang J; Wang P; Zang J; Zhao L
Radiat Oncol; 2023 Oct; 18(1):174. PubMed ID: 37891689
[TBL] [Abstract][Full Text] [Related]
27. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
28. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.
Williams MS; Burk M; Loprinzi CL; Hill M; Schomberg PJ; Nearhood K; O'Fallon JR; Laurie JA; Shanahan TG; Moore RL; Urias RE; Kuske RR; Engel RE; Eggleston WD
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):345-9. PubMed ID: 8892458
[TBL] [Abstract][Full Text] [Related]
29. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
30. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.
Hemati S; Asnaashari O; Sarvizadeh M; Motlagh BN; Akbari M; Tajvidi M; Gookizadeh A
Support Care Cancer; 2012 Aug; 20(8):1613-8. PubMed ID: 22006502
[TBL] [Abstract][Full Text] [Related]
31. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial.
Kirova YM; Fromantin I; De Rycke Y; Fourquet A; Morvan E; Padiglione S; Falcou MC; Campana F; Bollet MA
Radiother Oncol; 2011 Aug; 100(2):205-9. PubMed ID: 21624699
[TBL] [Abstract][Full Text] [Related]
32. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.
Shariati L; Amouheidari A; Naji Esfahani H; Abed A; Haghjooy Javanmard S; Laher I; Ghasemi A; Vaseghi G
Br J Clin Pharmacol; 2020 Sep; 86(9):1875-1881. PubMed ID: 32040868
[TBL] [Abstract][Full Text] [Related]
34. Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.
Cleary JF; Anderson BM; Eickhoff JC; Khuntia D; Fahl WE
Radiat Oncol; 2017 Dec; 12(1):201. PubMed ID: 29273054
[TBL] [Abstract][Full Text] [Related]
35. Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer.
Trombetta M; Julian TB; Valakh V; Greenberg L; Labban G; Khalid MK; Werts ED; Parda D
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1303-8. PubMed ID: 20044218
[TBL] [Abstract][Full Text] [Related]
36. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
[TBL] [Abstract][Full Text] [Related]
37. Reducing Radiation Dermatitis Using a Film-forming Silicone Gel During Breast Radiotherapy: A Pilot Randomized-controlled Trial.
Ahn S; Sung K; Kim HJ; Choi YE; Lee YK; Kim JS; Lee SK; Roh JY
In Vivo; 2020; 34(1):413-422. PubMed ID: 31882508
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
39. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
[TBL] [Abstract][Full Text] [Related]
40. Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience.
DeCesaris CM; Rice SR; Bentzen SM; Jatczak J; Mishra MV; Nichols EM
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1084-1090. PubMed ID: 31028831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
